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This study investigated the chemoprotective effects of Punica granatum L. (Punicaceae) fruits alcoholic 
extract (PGE) on mice exposed to hexavalent chromium [Cr(VI)]. Animals were pretreated with 
PGE (25, 50 or 75 mg/kg/day) for 10 days and subsequently exposed to a sub-lethal dose of Cr(VI)  
(30 mg/kg). The frequency of micronucleated polychromatic erythrocytes in the bone marrow was 
investigated and the Cr(VI) levels were measured in the kidneys, liver and plasm. For the survival 
analysis, mice were previously treated with PGE for 10 days and exposed to a single lethal dose of Cr(VI) 
(50 mg/kg). Exposure to a sub-lethal dose of Cr(VI) induced a significant increase in the frequency 
of micronucleated cells. However, the prophylactic treatment with PGE led to a reduction of 44.5%  
(25 mg/kg), 86.3% (50 mg/kg) and 64.2% (75 mg/kg) in the incidence of micronuclei. In addition, the 
50 mg/kg dose of PGE produced a higher chemoprotective effect, since the survival rate was 90%, when 
compared to that of the non-treated group. In these animals, reduced amounts of chromium were detected 
in the biological materials, in comparison with the other groups. Taken together, the results demonstrated 
that PGE exerts a protective effect against Cr(VI)-induced genotoxicity.
Uniterms: Chemoprevention. Hexavalent chromium/induced genotoxicity. Oxidative damage. 
Pomegranate/chemoprotective effects. Punica granatum/chemoprotective effects. Punica granatum/
pharmacognosy. Punicaceae/chemoprotective effects. Punicaceae/pharmacognosy.
Este estudo investigou os efeitos quimioprotetores do extrato alcoólico dos frutos da Punica granatum 
L. (Punicaceae) (EPG) em camundongos expostos ao cromo hexavalente [Cr(VI)]. Os animais foram 
pré-tratados com o EPG (25, 50 ou 75 mg/kg/dia) durante 10 dias e subsequentemente expostos a uma 
dose subletal de Cr(VI) (30 mg/kg). A frequência de eritrócitos policromáticos micronucleados na medula 
óssea foi investigada e os níveis de Cr(VI) foram quantificados nos rins, fígado e plasma. Para a análise 
de sobrevida, os camundongos foram previamente tratados com EPG durante 10 dias e expostos a única 
dose letal de Cr(VI) (50 mg/kg). A exposição à dose subletal de Cr(VI) induziu aumento significativo na 
frequência de células micronucleadas. Entretanto, o tratamento profilático com EPG levou à redução de 
44,5% (25 mg/kg), 86,3% (50 mg/kg) e 64,2% (75 mg/kg) na incidência de micronúcleo. Além disso, a 
dose de 50 mg/kg de EPG produziu maior efeito quimioprotetor, uma vez que a taxa de sobrevivência 
foi de 90%, quando comparada àquela do grupo não tratado. Nesses animais, quantidades reduzidas de 
cromo foram detectadas nos materiais biológicos, em comparação com os outros grupos. Em conjunto, os 
resultados demonstram que o EPG exerce efeito protetor contra a genotoxicidade induzida pelo Cr(VI).
Unitermos: Quimioprevenção. Cromo hexavalente/genotoxicidade induzida. Dano oxidative. Romã/
efeito quimioprotetor. Punica granatum/efeito quimioprotetor. Punica granatum/farmacognosia. 
Punicaceae/efeito quimioprotetor. Punicaceae/farmacognosia.
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INTRODUCTION
Chromium occurs naturally in the environment in 
different oxidation states, where Cr(III) and Cr(VI) are the 
most prevalent. The hexavalent form is usually linked with 
oxygen and is a strong oxidizing agent. Studies have shown 
that Cr(VI) is a mutagenic, carcinogenic and teratogenic 
agent, which easily penetrates the cell membrane in the 
form of chromate anion (Barceloux, 1999; Acharya et al., 
2006; Nickens et al., 2010; Chang et al., 2011; Okello et 
al., 2012). Its molecular mechanisms of toxicity are not 
yet fully known, but it is believed that the intracellular 
increase in the production of reactive oxygen species 
(ROS) is probably a key factor in inducing cell damage (Ye 
et al., 1999; Wu et al., 2012). These reactive species can 
cause damage to macromolecules such as DNA, proteins 
and lipids, thereby inhibiting their functions (Valko et al., 
2007; Yan et al., 2012) and may even trigger apoptotic cell 
death (Liu, Chen, 2006; Liu et al., 2008).
Cr(VI) has been widely used in metallurgical, 
refractory and chemical industries. It has been considered 
a potent occupational carcinogen among workers 
involved in electrodeposition, metal finishes/welding, 
wood preservatives, organic synthesis procedures and 
in leather tanning (Barceloux, 1999; Shrivastava et al., 
2002; Acharya et al., 2006; Nickens et al., 2010). In such 
activities occupational exposure to Cr(VI)-contaminated 
dust and aerosols occurs predominantly through inhalation 
or skin contact (Zagrodzki et al., 2007). Non-occupational 
exposure to Cr(VI) can also occur through cigarette smoke, 
automobile emissions and the inappropriate disposal of 
chromium-containing waste in the environment (O’Brien 
et al., 2003; Russo et al., 2005).
The literature has shown that the administration of 
antioxidant agents to animals exposed to Cr(VI) results 
in a reduction of bioavailability, nephrotoxicity and the 
mortality rate of these animals (Chow, 2002). Thus the 
use of antioxidant agents should be considered if the 
toxicological effects of this xenobiotic are reduced (Deb 
et al., 2012).
Pomegranate [Punica granatum L. (Punicaceae)] 
has been reported to be a rich source of bioactive 
polyphenols, compounds with antioxidant properties, 
such as anthocyanins, hydrolysable and condensed tannins 
(Sudheesh, Vijayalakshmi, 2005; Lansky, Newman, 
2007; Wang et al., 2010). Various therapeutic properties 
are commonly attributed to this fruit. These include 
anti-inflammatory, antitumoral, diabetes prevention/
treatment, antiulcer, antimicrobial, antiangiogenic, 
immunomodulating and antioxidant activities. The 
medicinal properties of this fruit have been widely 
investigated and numerous scientific papers have 
corroborated with its popular use (Prashanth et al., 2001; 
Braga et al., 2005; Menezes et al., 2006; Vasconcelos 
et al., 2006; Aquil, Ahmad, 2007; Oliveira et al., 2010; 
Johanningsmeier, Harris, 2011).
Analyses of the antioxidant property of pomegranate 
have shown that this fruit is superior to other foods in terms 
of antioxidant effects, such as red wine, cranberries and 
green tea (Seeram et al., 2008). Moreover certain reports 
have shown considerable antioxidant activities of Punica 
granatum in several in vitro and in vivo experimental 
models (Chidambara et al., 2002; Cerda et al., 2003; Ricci 
et al., 2006; Bishayee et al., 2011). Such effects have been 
attributed to its effective action against ROS (Ozgen et al., 
2008). As a consequence, Punica granatum is recognized 
as a potent chemoprotective agent and adjuvant in cancer 
treatment (Syed et al., 2007). Our research group recently 
demonstrated that pomegranate alcoholic extract exerts 
antimutagenic activity against cyclophosphamide-induced 
DNA damage (Valadares et al., 2010). Additionally this 
extract showed in vitro cytotoxic and in vivo antitumor 
activity due to its inhibition of Ehrlich ascites tumour 
growth, along with a decrease in the vascular pattern of 
the peritoneal wall and a consequent increase in survival 
time on mice (Oliveira et al., 2010).
Considering that  there is  an ever growing 
worldwide risk of chromium poisoning in the aftermath 
of occupational exposure (Fen et al., 2012), and with all 
the above-described date, as a background, this study 
set out to investigate the chemoprotective properties of 
Punica granatum L. fruits alcoholic extract (PGE) for 
mice exposed to Cr(VI).
MATERIAL AND METHODS
Botanical material
Punica granatum fruits were collected in the city of 
Goiânia, Goiás, Brazil (768 m altitude; 16º 40’ 33.3’’ South; 
49º 14’ 39.5’’ West). The voucher specimens were deposited 
in the Federal University of the State of Goiás herbarium 
under the identification UFG-41497, Goiânia, GO. The 
fruits were dried in a ventilated oven at 36 °C, pulverized, 
macerated in 95% ethanol and rotaevaporated according to 
guidelines of the Brazilian Pharmacopoeia (1977).
Animals and treatment
The experimental study was approved by the 
Ethics Committee for the Use of Animals of University 
of Goiás, in accordance with institutional protocols and 
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the guidelines of the Institutional Animal Care and Use 
Committee, which follows the recommendations of the 
Canadian Council on Animal Care (Olfert et al., 1993).
Swiss male mice (body weight: 30-38 g; age: 7-10 
weeks) were obtained from Chemical Industry of the 
State of Goiás (IQUEGO). All animals were kept under 
constant environmental conditions with light-dark cycles 
and controlled temperature. Water and food were provided 
ad libitum.
Punica granatum alcoholic extract (PGE) was diluted 
in saline and Tween 80 (10%) for administration in animals. 
It was administered orally (gavage) in single daily doses of 
25, 50 or 75 mg/kg for 10 days and subsequent exposure 
to Cr(VI), on the 11th day. For chemoprotection assay and 
survival evaluation, it was administered 30 mg/kg (sub-
lethal dose) and 50 mg/kg (lethal dose) of Cr(VI) (potassium 
dichromate) intraperitoneally, respectively. Treatment 
groups were distributed as follows: Group I: PGE solvent; 
Group II: Cr(VI); Group III: 25 mg/kg PGE + Cr(VI); 
Group IV: 50 mg/kg PGE + Cr(VI); Group V: 75 mg/kg 
PGE + Cr(VI). These doses of PGE were chosen according 
previous studies from our group (Valadares etal., 2010).
Investigation of chemoprotective effect of PGE
The animals (n=6 per group) were euthanized on 
the 12th day and bone marrow cells and kidneys, liver 
and plasma were obtained to micronuclei assay and 
determination of the Cr(VI) levels, respectively.
The micronucleus test was realized based on 
MacGregor et al. (1987) and Valadares et al. (2010). For 
each animal, three slides were made and stained with 
Giemsa dye. 1000 bone marrow cells for each animal 
were scored in a blind test using a light microscope 
(1000x magnification) and the number of micronucleated 
polychromatic erythrocytes (MNPCE) was determined. 
The frequency of MNPCE in each mouse was used as 
the experimental unit. The percentage of reduction in the 
frequency of micronuclei was calculated according to 
Manoharan and Banerjee (1985), as the following formula: 
% reduction = (mean frequency of damage in A - mean 
frequency of damage in B)/(mean frequency of damage 
in A - mean frequency of damage in C) x 100. Where, 
A = group exposed to Cr(VI) and without prophylactic 
treatment with PGE (Group II), B = group treated with 
PGE and exposed to Cr(VI) (Groups III, IV and V), 
C = group treated with the solvent from the PGE (Group I).
Determination of the Cr levels
The Cr(VI) concentrations in plasma, kidneys 
and liver were measured using a AA 400 Flame Atomic 
Absorption Spectrometer (FAAS- Perkin Elmer, USA) 
with a chromium hollow cathode lamp (357.8 nm). 
Chromium determination procedure is based on sample 
incineration and solubilization in nitric acid, according 
to official methods of analysis (Association of official 
analytical Chemists – AOAC, 1990).
The samples were prepared by wet-digestion using 
HNO3 (65%) and H2O2 (30%), and diluted to a final 
volume of 50 mL with ultrapure water for the chromium 
determination. The optimum operation conditions were 
20 nm band width, 25 mA lamp current and 2.5 mL.min-1 
acetylene flow rate in an air/acetylene flame. The chromium 
quantification was carried out using multiple standard 
additions in the prepared solutions e the results were 
expressed in the amount of Cr presents in each organ or 
plasm pool. A minimum of three replicate analyses was 
performed for each sample. Five solutions, each containing 
3.0 mL of organ sample solution , were prepared by 
additions of 0, 50, 200, 350, and 500 µL of 200 mg/L 
chromium stock solution (prepared using CrO3 in HNO3 
5%) for a 5 mL final volume. The results of mice group 
exposed to Cr(VI) only were used as a comparison with the 
groups pretreated with PGE and exposed to this toxic metal.
Survival curve
For the survival test, three groups of animals (n = 10 
per group) were previously treated during 10 days by 
gavage with different PGE doses (25, 50 or 75 mg/kg) and 
Cr(VI) group received only saline and Tween 80 (10%) 
solution. On the 11th day, all groups were exposed to the 
Cr(VI). From 12th day, the rate of survival of the animals 
was monitored. At the end of the study, the surviving 
animals were euthanized (day 30).
Statistical analysis
Survival was evaluated by the Kaplan-Meier test and 
Log-Rank test a posteriori. Micronuclei frequency and Cr 
levels in biological tissues were analyzed by the one-way 
Analysis of Variance (ANOVA) followed by Tukey’s test. 
Statistical significance was established as p<0.05.
RESULTS
Investigation of the chemoprotective effect
Cr(VI) exposure induced a significant increase in the 
frequency of MNPCE, as compared to that of the control 
group (p<0.05). On the other hand, prophylactic treatment 
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Quantification of Cr levels
As shown in Figure 2, only those mice exposed 
to a sub-lethal dose of Cr(VI) showed an increase in Cr 
levels, in contrast with the animals pretreated with 25 
and 50 mg/kg doses of PGE. Treatment with these doses 
significantly reduced the Cr levels in plasm, kidneys and 
liver (p<0.001), while mice pretreated with 75 mg/kg of 
PGE showed Cr levels similar to the Cr(VI) group.
Survival analysis
All the mice exposed to a single Cr(VI) lethal dose 
(50 mg/kg) died between 12th and 14th day. On the other 
hand, treatment with PGE doses increased the survival rate 
of the animals exposed to this toxic metal. The 50 mg/kg 
dose of PGE presented the best survival rate, since 90% 
of the animals survived until the end of the assay, while 25 
mg/kg and 75 mg/Kg of PGE gave rates of 60 and 30%, 
respectively (p = 0.0096) (Figure 3).
DISCUSSION
Cr(VI) has been shown to induce chromosomal 
aberrations and mutations (Balansky et al., 2000; 
O’Brien et al., 2003; Rodriguez et al., 2011). In this 
study, as expected, it was detected that Cr(VI) led 
to an increase in the frequency of micronucleated 
polychromatic erythrocytes. In contrast, PGE reduced 
micronuclei frequency, especially at 50 mg/kg dose, thus 
showing its chemoprotective property. The antigenotoxic 
FIGURE 1 – Effects of prophylactic oral treatment with PGE 
(25, 50, and 75 mg/kg/day) for 10 days on the frequency of 
micronucleated polychromatic erythrocytes (MNPCE) in 
mice exposed to a sub-lethal dose of Cr(VI) (30 mg/kg). Each 
bar presents mean±SD. (**p<0.01 vs. control; #p<0.05 and 
##p<0.01 vs. Cr(VI). One way ANOVA and Tukey’s test, 
p<0.05).
FIGURE 2 – Chromium levels present in each plasm (A), kidneys (B) and liver (C) pool of mice pretreated with PGE (25, 50 and 
75 mg/kg) and exposed to a sub-lethal dose of Cr(VI) (30 mg/kg). The chromium quantification was carried out using multiple 
standard additions in the prepared solutions and the results were expressed in the amount of Cr present in each organ or plasm 
pool. Each bar presents mean±SD of three replicate analyses for each sample. (**p<0.01 and ***p<0.001 vs. Cr(VI). One way 
ANOVA and Tukey’s test, p<0.05).
with PGE followed by exposure to Cr(VI) produced a 
significant reduction in the frequency of micronuclei 
(p<0.05) (Figure 1). The study found that animals 
pretreated with 25, 50, or 75 mg/kg of PGE showed 
reductions of 44.5, 86.3 and 64.2% in the incidence of 
micronuclei, respectively. In a preliminary study, similar 
results were observed when animals exposed to Cr(VI) 
were therapeutically treated with PGE, i.e., the treatment 
was given after exposure (data not shown).
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potential of the Punica granatum leaf for protecting 
against cyclophosphamide-induced DNA damage in 
mice has also been reported (Dassprakash et al., 2012). 
Chidambara et al. (2002) showed the chemoprotective 
effect on rats pretreated with 50 mg/kg of pomegranate 
peel and then exposed to carbon tetrachloride (CCl4). 
In this study, hepatic parameters such as catalase, 
peroxidase, superoxide dismutase and lipid peroxidation 
were restored to normal values and histopathological 
damage was prevented. Similar findings were shown 
in the hepatic (Pirinccioglu et al., 2012) and renal 
(Moneim, El-Khadragy, 2012) tissue of rats pretreated 
with pomegranate juice and exposed to CCl4. Moreover, 
pomegranate seeds attenuated cisplatin-induced acute 
nephrotoxicity and hepatotoxicity in rats probably due 
to their antioxidant, radical-scavenging and antiapoptotic 
effects (Cayır et al., 2011).
These chemoprotective properties assigned to 
Punica granatum are quite interesting, since kidneys 
and liver are essential organs for maintaining body 
homeostasis and are susceptible to drug and chemical 
effects which may cause renal and liver dysfunction 
(Cayır et al., 2011). Because of that, attention has been 
focused on the toxic action of Cr(VI), since it is highly 
hepatotoxic (Rafael et al., 2007) and nephrotoxic (Khan 
et al., 2010; Molina-Jijón et al., 2011). Moreover, certain 
studies have indicated that this metal accumulates in 
the liver and kidneys (Sutherland et al., 2000; O’Brien 
et al., 2003; Collins et al., 2010; Chang et al., 2011), 
corroborating the results found here. However, the 
mice pretreated with the 25 and 50 mg/kg doses of PGE 
showed an interesting change in the bioavailability of 
FIGURE 3 - Survival analysis of animals prophylactically 
t r e a t e d  w i t h  d i f f e r e n t  P G E  d o s e s  ( 2 5 ,  5 0  a n d 
75 mg/kg/day) for 10 days and exposed to a lethal dose of Cr(VI) 
(50 mg/kg) on the 11th day. The survival rate was monitored 
until the 30nd day. (p = 0.0096. Kaplan-Meier test and Log-Rank 
test, p<0.05).
chromium, since its levels in the kidney, liver and plasma 
were reduced. The best results were observed with the 
50mg/kg/day dose. In this respect, Bishayee et al. (2011) 
found that pomegranate may act through the induction of 
Nrf2-regulated cytoprotective enzymes, which results in 
enhancing the excretion of the electrophilic carcinogen 
and reducing the formation of free radicals inductors of 
tumorigenesis. In contrast, the 75 mg/kg dose of PGE did 
not affect the bioavailability of this xenobiotic. Sánchez-
Lamar et al. (2008) observed that pomegranate is toxic, 
i.e. genotoxic to mice at doses greater than or equal to 
70 mg/kg.
Published reports have shown that the use of natural 
products rich in antioxidants, such as polyphenols, can 
reduce the toxic effects of Cr(VI) (Arreola-Mendoza et al., 
2006; Kalayarasan et al., 2008; Pedraza-Chaverri et al., 
2008; Guha et al., 2010; Khan et al., 2010; Molina-Jijón 
et al., 2011; Deb et al., 2012). Thus, the chemoprotective 
effect demonstrated here may be related, at least in part, 
to the reduction of Cr(VI)-induced oxidative stress, since 
pomegranate contains polyphenols with antioxidant 
properties, such as punicalin and punicalagin, its main 
metabolites. Moreover, one cannot exclude the possibility 
of this fruit exerting a chelating effect, probably due 
to the presence of tannins, which are widely studied 
as chelating agents (Urquiaga, Leighton, 2000; Chin 
et al., 2009; Karamac, 2009a). In particular, these 
bioactive phytoconstituents exhibit strong antioxidant 
properties when compared to phenolic compounds 
of low molecular weight(Amarowicz et al., 2005). In 
addition, its antioxidant properties can result from free 
radical scavenging activities but ability to chelate metal 
ions also play an important role (Karamac, 2009b). It 
has been considered that the binding of metal ions with 
tannins can stabilize the oxidative damage produced by 
these ions (Andrade et al., 2005). Moreover, pomegranate 
bark converted into activated carbon has been identified 
as an effective adsorbent for removing Cr(VI) ions from 
wastewater (Nemr, 2009). Okello et al. (2012) also showed 
Cr(VI) being removed from environmental samples 
using quercetin, a naturally occurring flavonoid, and its 
two synthetic derivates, quercetin pentaphosphate and 
quercetin sulfonic acid.
The results of this study indicate that PGE 
protected against the genotoxicity induced by Cr(VI). 
However further studies are needed to elucidate the exact 
mechanisms involved in the protective effects of PGE 
against the damage induced by chromium. Moreover 
studies with individual phenolic compounds of this fruit 
could be undertaken to elucidate the different protective 
mechanisms and possible associated effects.
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